An interventional study of Exo-Assisted in Stroke, sponsored by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-26.
Sponsored by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 346 studies in Stroke with a site in Italy — 93 open to participants now, 106 under way, 3 of them phase 3. Stroke · Italy.
Among the 346 studies in Stroke with a site in Italy, this one is the 236th largest by planned enrollment of the 264 interventional ones that give a count, is one of 15 that started in 2026, is one of 208 with no phase, reaches primary completion later than 49 of the 105 other live ones, and was the 332nd registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →93 of the 346 studies in Stroke with a site in Italy are open now. Recruiting first, the newest first:
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Sites in Italy
Ages 18+
Hospital Universitari Vall d'Hebron Research Institute · Sites in Italy, Belgium, Germany and 3 more countries
Ages 18+
Dr. Yaroslav Winter · Sites in Italy, Czechia, Germany and 1 more country
Azienda Unita Sanitaria Locale di Piacenza · Sites in Italy
Ages 18+
University of Foggia · Sites in Italy
Ages 18–80
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
346 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 15 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 76 across the 264 interventional studies, 250 across the 82 observational. Of the 193 that completed or were terminated, 33 (17%) have results posted.
This tab as a report to print or save as PDF → With an account.
63 of 346 have an industry lead sponsor. The 10 most frequent:
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna is the lead sponsor of 5 studies on the registry; 3 are open to participants now.
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna has 1 study filed under Stroke — fewer than ten, so there is no comparison to draw.
34 of the studies in Stroke with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06547827Fondazione Don Carlo Gnocchi ETSRehabilitation With and Without Robot and Allied Digital Technologies in Stroke Patients | 2026-11 |
| NCT06710028Fondazione Policlinico Universitario Agostino Gemelli IRCCSTrustworthy Artificial Intelligence for Improvement of Stroke Outcomes | 2026-11-30 |
| NCT07670325Scuola Superiore di Studi Universitari e di Perfezionamento Sant'AnnaFuncitonality and Safety of a Knee Device for Gait Rehabilitation in Neurological Patients | 2026-11-30 |
| NCT04559724IRCCS San Raffaele RomaGait Training Through a Novel Over-ground Wearable Robotic System in People With Pyramidal Hemisyndromes | 2026-12 |
| NCT07637123IRCCS San Raffaele RomaEvaluation of a Soft Elbow Exoskeleton and a Haptic Armband in Post-stroke and Parkinson's Disease Patients | 2026-12 |
Add all 34 to your calendar (.ics) → With an account.
Among the 346 studies in Stroke with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This clinical investigation aims to evaluate the safety, feasibility, and preliminary performance of the AKO-R wearable robotic device for knee assistance during walking. The study involves participants performing treadmill and overground gait training under supervised conditions, with the device providing assistive torque to support movement. Clinical and functional outcomes are assessed using validated measurement tools, while additional data are collected to characterize user performance and interaction with the device. The study is designed as an exploratory investigation to gather evidence supporting the clinical use and further development of the device. Primary outcomes regards safety of the device and preliminary clinical benefit on gait symmetry.
The study is structured in 5 sessions. The first and last session are the assessment. the 2nd session is the session for calibration of the exoskeleton parameters. The 3rd session is for exo familiarization and the 4th exo is for exo-assisted condition evaluation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients perform gait training on treadmill and overground with assistance of the investigational device
Device: Exo-Assisted
Participants perform gait training assiste by the knee exoskeletn investigational device
Number of device-related adverse events
Time frame: through study completion, an average of 1 year
Step Length Symmetry Index Change
The Step Length Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across \>20 steps. Score closer to 0 means a better outcome.
Time frame: Day 4
Stance Time Symmetry Index Change
The Stance Time Symmetry Index (SI) will be compared across conditions. Descriptive data are averaged across \>20 steps. Score closer to 0 means a better outcome.
Time frame: Day 4
Range of motion Change
The Range of motion (computed as difference between minimum and maximum joint angle in a step) will be compared across conditions. Descriptive data are averaged across \>20 steps
Time frame: Day 4
Self-selected velocity Change
Effect of 3 sessions on self-selected velocity, compared with Session 1. Evaluated with 10 meter walking test
Time frame: Day 5
Endurance
Effect of 3 sessions on endurance, compared with Session 1. Evaluated with 2 minute walking test.
Time frame: Day 5
Usability score
Evaluated with System Usability Scale (SUS) questionnaire. The SUS score ranges from a minimum of 0 to a maximum of 100.
Time frame: Day 5
Acceptability
Evaluated with Technology Acceptance Model (TAM) questionnaire. The TAM score goes from a minimum of 0 to a maximum score of 100.
Time frame: Day 5
Satisfaction Score
Evaluated with Quebec User Evaluation of Satisfaction with assistive Technology 2.0 (QUEST 2.0). The QUEST goes from a minimum of 0 to a maximum of 100.
Time frame: Day 5
Started Jun 2026 (actual). Primary completion is estimated for Nov 2026, 5 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 5 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna